# MSCI Inc.: financial statements, quarterly

MSCI · NYSE · CIK 1408198 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/msci.md) · [Financials](/companies/msci/financials.md) · [Filings](/companies/msci/filings.md) · [Insiders](/companies/msci/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/msci/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [690 d](/filings/0001408198-26-000011.md) | [680](/filings/0001408198-25-000111.md) | [708](/filings/0001408198-25-000177.md) | [725](/filings/0001408198-25-000196.md) | [744 d](/filings/0001408198-26-000011.md) | [746](/filings/0001408198-26-000034.md) | [773](/filings/0001408198-26-000046.md) | [793](/filings/0001408198-26-000056.md) | [823 d](/filings/0001408198-26-000011.md) | [851](/filings/0001408198-26-000034.md) | [867](/filings/0001408198-26-000046.md) | [892](/filings/0001408198-26-000056.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [39.2 d](/filings/0001408198-26-000011.md) | [40.5](/filings/0001408198-25-000111.md) | [41.1](/filings/0001408198-25-000177.md) | [38.6](/filings/0001408198-25-000196.md) | [38.5 d](/filings/0001408198-26-000011.md) | [47.6](/filings/0001408198-26-000034.md) | [44.1](/filings/0001408198-26-000046.md) | [44.8](/filings/0001408198-26-000056.md) | [41.1 d](/filings/0001408198-26-000011.md) | [49.6](/filings/0001408198-26-000034.md) | [46.0](/filings/0001408198-26-000046.md) | [47.6](/filings/0001408198-26-000056.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [371 d](/filings/0001408198-26-000011.md) | [339](/filings/0001408198-25-000111.md) | [383](/filings/0001408198-25-000177.md) | [401](/filings/0001408198-25-000196.md) | [405 d](/filings/0001408198-26-000011.md) | [377](/filings/0001408198-26-000034.md) | [425](/filings/0001408198-26-000046.md) | [448](/filings/0001408198-26-000056.md) | [464 d](/filings/0001408198-26-000011.md) | [457](/filings/0001408198-26-000034.md) | [488](/filings/0001408198-26-000046.md) | [502](/filings/0001408198-26-000056.md) |
| Interest expense | $m | [47.0 d](/filings/0001408198-24-000030.md) | [46.7](/filings/0001408198-24-000075.md) | [46.6](/filings/0001408198-25-000177.md) | [46.7](/filings/0001408198-25-000196.md) | [45.5 d](/filings/0001408198-26-000011.md) | [46.5](/filings/0001408198-26-000034.md) | [46.2](/filings/0001408198-26-000046.md) | [53.6](/filings/0001408198-26-000056.md) | [63.6 d](/filings/0001408198-26-000011.md) | [69.1](/filings/0001408198-26-000034.md) | [71.0](/filings/0001408198-26-000046.md) | [74.8](/filings/0001408198-26-000056.md) |
| Income tax | $m | [64.5 d](/filings/0001408198-26-000011.md) | [39.9](/filings/0001408198-25-000111.md) | [73.2](/filings/0001408198-25-000177.md) | [76.0](/filings/0001408198-25-000196.md) | [57.8 d](/filings/0001408198-26-000011.md) | [42.5](/filings/0001408198-26-000034.md) | [74.1](/filings/0001408198-26-000046.md) | [71.2](/filings/0001408198-26-000056.md) | [104 d](/filings/0001408198-26-000011.md) | [(16.8)](/filings/0001408198-26-000034.md) | [75.3](/filings/0001408198-26-000046.md) | [76.9](/filings/0001408198-26-000056.md) |
| Net income | $m | [403 d](/filings/0001408198-26-000011.md) | [256](/filings/0001408198-25-000196.md) | [267](/filings/0001408198-25-000196.md) | [281](/filings/0001408198-25-000196.md) | [306 d](/filings/0001408198-26-000011.md) | [289](/filings/0001408198-26-000056.md) | [304](/filings/0001408198-26-000056.md) | [325](/filings/0001408198-26-000056.md) | [285 d](/filings/0001408198-26-000011.md) | [406](/filings/0001408198-26-000056.md) | [342](/filings/0001408198-26-000056.md) | [351](/filings/0001408198-26-000056.md) |
| Diluted EPS | $ per share | not reported | [3.22](/filings/0001408198-25-000111.md) | [3.37](/filings/0001408198-25-000177.md) | [3.57](/filings/0001408198-25-000196.md) | not reported | [3.71](/filings/0001408198-26-000034.md) | [3.92](/filings/0001408198-26-000046.md) | [4.25](/filings/0001408198-26-000056.md) | not reported | [5.53](/filings/0001408198-26-000034.md) | [4.69](/filings/0001408198-26-000046.md) | [4.86](/filings/0001408198-26-000056.md) |
| Basic EPS | $ per share | not reported | [3.23](/filings/0001408198-25-000111.md) | [3.37](/filings/0001408198-25-000177.md) | [3.58](/filings/0001408198-25-000196.md) | not reported | [3.72](/filings/0001408198-26-000034.md) | [3.92](/filings/0001408198-26-000046.md) | [4.26](/filings/0001408198-26-000056.md) | not reported | [5.54](/filings/0001408198-26-000034.md) | [4.70](/filings/0001408198-26-000046.md) | [4.87](/filings/0001408198-26-000056.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [462](/filings/0001408198-25-000053.md) | [519](/filings/0001408198-24-000075.md) | [451](/filings/0001408198-24-000131.md) | [501](/filings/0001408198-24-000170.md) | [409](/filings/0001408198-26-000011.md) | [361](/filings/0001408198-25-000111.md) | [347](/filings/0001408198-25-000177.md) | [400](/filings/0001408198-25-000196.md) | [515](/filings/0001408198-26-000056.md) | [385](/filings/0001408198-26-000034.md) | [356](/filings/0001408198-26-000046.md) | [261](/filings/0001408198-26-000056.md) |
| Current assets | $m | [1,418](/filings/0001408198-25-000053.md) | [1,365](/filings/0001408198-24-000075.md) | [1,315](/filings/0001408198-24-000131.md) | [1,286](/filings/0001408198-24-000170.md) | [1,344](/filings/0001408198-26-000011.md) | [1,236](/filings/0001408198-25-000111.md) | [1,271](/filings/0001408198-25-000177.md) | [1,309](/filings/0001408198-25-000196.md) | [1,645](/filings/0001408198-26-000056.md) | [1,394](/filings/0001408198-26-000034.md) | [1,436](/filings/0001408198-26-000046.md) | [1,299](/filings/0001408198-26-000056.md) |
| Total assets | $m | [5,518](/filings/0001408198-25-000053.md) | [5,479](/filings/0001408198-24-000075.md) | [5,457](/filings/0001408198-24-000131.md) | [5,409](/filings/0001408198-24-000170.md) | [5,445](/filings/0001408198-26-000011.md) | [5,344](/filings/0001408198-25-000111.md) | [5,374](/filings/0001408198-25-000177.md) | [5,389](/filings/0001408198-25-000196.md) | [5,703](/filings/0001408198-26-000056.md) | [5,545](/filings/0001408198-26-000034.md) | [5,603](/filings/0001408198-26-000046.md) | [5,595](/filings/0001408198-26-000056.md) |
| Current liabilities | $m | [1,517](/filings/0001408198-25-000053.md) | [1,369](/filings/0001408198-24-000075.md) | [1,376](/filings/0001408198-24-000131.md) | [1,378](/filings/0001408198-24-000170.md) | [1,586](/filings/0001408198-26-000011.md) | [1,466](/filings/0001408198-25-000111.md) | [1,470](/filings/0001408198-25-000177.md) | [1,484](/filings/0001408198-25-000196.md) | [1,830](/filings/0001408198-26-000056.md) | [1,613](/filings/0001408198-26-000034.md) | [1,606](/filings/0001408198-26-000046.md) | [1,575](/filings/0001408198-26-000056.md) |
| Total liabilities | $m | [6,258](/filings/0001408198-25-000053.md) | [6,129](/filings/0001408198-24-000075.md) | [6,191](/filings/0001408198-24-000131.md) | [6,160](/filings/0001408198-24-000170.md) | [6,385](/filings/0001408198-26-000011.md) | [6,303](/filings/0001408198-25-000111.md) | [6,260](/filings/0001408198-25-000177.md) | [7,305](/filings/0001408198-25-000196.md) | [8,357](/filings/0001408198-26-000056.md) | [8,319](/filings/0001408198-26-000034.md) | [8,292](/filings/0001408198-26-000046.md) | [8,612](/filings/0001408198-26-000056.md) |
| Long-term debt | $m | [4,497](/filings/0001408198-25-000053.md) | [4,508](/filings/0001408198-24-000075.md) | [4,509](/filings/0001408198-24-000131.md) | [4,485](/filings/0001408198-24-000170.md) | [4,511](/filings/0001408198-26-000011.md) | [4,547](/filings/0001408198-25-000111.md) | [4,513](/filings/0001408198-25-000177.md) | [5,508](/filings/0001408198-25-000196.md) | [6,202](/filings/0001408198-26-000056.md) | [6,404](/filings/0001408198-26-000034.md) | [6,380](/filings/0001408198-26-000046.md) | [6,717](/filings/0001408198-26-000056.md) |
| Current portion of debt | $m | [10.9](/filings/0001408198-25-000053.md) | [0.0](/filings/0001408198-24-000075.md) | [0.0](/filings/0001408198-24-000131.md) | [0.0](/filings/0001408198-24-000170.md) | [0.0](/filings/0001408198-25-000053.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(740)](/filings/0001408198-26-000011.md) | [(651)](/filings/0001408198-25-000196.md) | [(734)](/filings/0001408198-25-000196.md) | [(751)](/filings/0001408198-25-000196.md) | [(940)](/filings/0001408198-26-000056.md) | [(959)](/filings/0001408198-26-000056.md) | [(886)](/filings/0001408198-26-000056.md) | [(1,916)](/filings/0001408198-26-000056.md) | [(2,655)](/filings/0001408198-26-000056.md) | [(2,774)](/filings/0001408198-26-000056.md) | [(2,690)](/filings/0001408198-26-000056.md) | [(3,016)](/filings/0001408198-26-000056.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [389 d](/filings/0001408198-26-000011.md) | [300](/filings/0001408198-25-000111.md) | [349 d](/filings/0001408198-25-000177.md) | [422 d](/filings/0001408198-25-000196.md) | [431 d](/filings/0001408198-26-000011.md) | [302](/filings/0001408198-26-000034.md) | [336 d](/filings/0001408198-26-000046.md) | [449 d](/filings/0001408198-26-000056.md) | [501 d](/filings/0001408198-26-000011.md) | [307](/filings/0001408198-26-000034.md) | [371 d](/filings/0001408198-26-000046.md) | [436 d](/filings/0001408198-26-000056.md) |
| Capital expenditure | $m | [3.8 d](/filings/0001408198-26-000011.md) | [4.3](/filings/0001408198-25-000111.md) | [8.6 d](/filings/0001408198-25-000177.md) | [6.6 d](/filings/0001408198-25-000196.md) | [14.2 d](/filings/0001408198-26-000011.md) | [11.6](/filings/0001408198-26-000034.md) | [11.3 d](/filings/0001408198-26-000046.md) | [4.0 d](/filings/0001408198-26-000056.md) | [12.4 d](/filings/0001408198-26-000011.md) | [2.8](/filings/0001408198-26-000034.md) | [11.0 d](/filings/0001408198-26-000046.md) | [13.4 d](/filings/0001408198-26-000056.md) |
| Dividends paid | $m | [109 d](/filings/0001408198-26-000011.md) | [131](/filings/0001408198-25-000111.md) | [127 d](/filings/0001408198-25-000177.md) | [126 d](/filings/0001408198-25-000196.md) | [125 d](/filings/0001408198-26-000011.md) | [144](/filings/0001408198-26-000034.md) | [140 d](/filings/0001408198-26-000046.md) | [138 d](/filings/0001408198-26-000056.md) | [135 d](/filings/0001408198-26-000011.md) | [151](/filings/0001408198-26-000034.md) | [150 d](/filings/0001408198-26-000046.md) | [148 d](/filings/0001408198-26-000056.md) |
| Share repurchases | $m | [0.0 d](/filings/0001408198-26-000011.md) | [70.0](/filings/0001408198-25-000111.md) | [242 d](/filings/0001408198-25-000177.md) | [200 d](/filings/0001408198-25-000196.md) | [374 d](/filings/0001408198-26-000011.md) | [213](/filings/0001408198-26-000034.md) | [139 d](/filings/0001408198-26-000046.md) | [1,226 d](/filings/0001408198-26-000056.md) | [907 d](/filings/0001408198-26-000011.md) | [415](/filings/0001408198-26-000034.md) | [168 d](/filings/0001408198-26-000046.md) | [553 d](/filings/0001408198-26-000056.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [80.5](/filings/0001408198-24-000075.md) | [79.9](/filings/0001408198-24-000131.md) | [79.5](/filings/0001408198-24-000170.md) | [79.5](/filings/0001408198-25-000111.md) | [79.2](/filings/0001408198-25-000177.md) | [78.7](/filings/0001408198-25-000196.md) | [77.8](/filings/0001408198-26-000034.md) | [77.5](/filings/0001408198-26-000046.md) | [76.6](/filings/0001408198-26-000056.md) | [73.4](/filings/0001408198-26-000034.md) | [72.9](/filings/0001408198-26-000046.md) | [72.3](/filings/0001408198-26-000056.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 71,500,000 at 2026-10-13, from the cover of the [10-Q filed 2026-10-20](/filings/0001408198-26-000056.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.